Biofrontera

Biofrontera Depreciation & Amortization

The Depreciation & Amortization of Biofrontera (B8FK.DE) as of Nov 21, 2026 is 660,000.00 EUR. In the previous year, Depreciation & Amortization was 640,000.00 EUR — a change of 3.13% (higher).

Depreciation & Amortization

660,000.00EUR

YoY

3.13%

Last updated:

Depreciation & Amortization of Biofrontera is 2024 660,000.00 EUR. Depreciation & Amortization of Biofrontera was 2023 640,000.00 EUR. It decreases by 3.13% higher compared to the previous year.

The Biofrontera Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2021
3.16 M EUR
Jan 1, 2022
616,000.00 EUR
Jan 1, 2023
640,000.00 EUR
Jan 1, 2024
660,000.00 EUR
The Biofrontera Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
660,000.00EUR+3.13%
640,000.00EUR+3.90%
616,000.00EUR-80.49%
3.16 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biofrontera Stock analysis

What does Biofrontera do? Biofrontera AG generates revenue by developing, selling, and distributing dermatological drugs and medical cosmetics for skin care, protection, and treatment. The company markets its portfolio which includes Ameluz for the photodynamic therapy of actinic keratoses, the PDT lamp BF-RhodoLED used in conjunction with Ameluz treatment, and Belixos, a herbal dermatological cream for conditions such as insect bites, burns, neurodermatitis, and psoriasis. These products address the needs of patients and healthcare providers seeking treatments for skin diseases and regenerative care of damaged skin. The firm also engages in the clinical development of drug candidates to expand its future revenue streams. This includes BF-derm1, a tablet containing an inhibitor that blocks histamine synthesis to prevent allergic reactions, and BF1, a selective serotonin receptor agent aimed at preventing migraines. Through its five wholly owned subsidiaries, notably B, Biofrontera AG supports these development and distribution activities from its headquarters in Leverkusen, Nordrhein-Westfalen. Biofrontera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biofrontera stock

Depreciation & Amortization of Biofrontera is 660,000.00 EUR in 2024.

Depreciation & Amortization of Biofrontera changed from 640,000.00 EUR to 660,000.00 EUR, representing a 3.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization Biofrontera since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Biofrontera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Biofrontera

All Key Metrics — Biofrontera